European Association for the Study of the Liver

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1002/hep.32163 Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases
https://doi.org/10.1038/s41581-021-00425-3 Organ donation and transplantation: a multi-stakeholder call to action
https://doi.org/10.1016/j.jhep.2023.04.035 A global research priority agenda to advance public health responses to fatty liver disease
https://doi.org/10.1111/jvh.12875 Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe
https://doi.org/10.1097/hep.0000000000000545 A global action agenda for turning the tide on fatty liver disease
https://doi.org/10.1111/liv.15941 Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers
https://doi.org/10.1186/s12916-017-0856-y Late presentation of chronic viral hepatitis for medical care: a consensus definition
https://doi.org/10.1016/j.jhep.2023.07.029 Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives
https://doi.org/10.1016/j.jhep.2019.06.026 Excellence in viral hepatitis elimination – Lessons from Georgia
https://doi.org/10.1016/s0140-6736(18)31734-3 The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities
https://doi.org/10.1053/j.gastro.2022.02.020 The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary
https://doi.org/10.1016/j.jhep.2023.10.008 Reply to: “From NAFLD to MASLD: Promise and pitfalls of a new definition”
https://doi.org/10.1016/j.jtha.2024.08.018 The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
https://doi.org/10.1016/j.jhep.2023.12.011 Advocating for the implementation of the new nomenclature for steatotic liver disease: A call to action for the national associations
https://doi.org/10.1016/j.jhep.2022.02.012 The negative bidirectional interaction between climate change and the prevalence and care of liver disease: A joint BSG, BASL, EASL, and AASLD commentary
https://doi.org/10.1016/s0168-8278(23)00603-7 A global research priority agenda to advance public health responses to fatty liver disease
https://doi.org/10.1097/hc9.0000000000000273 Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
https://doi.org/10.1097/hep.0000000000000705 Reply: ‘From NAFLD to MASLD: Promise and pitfalls of a new definition’†
https://doi.org/10.1016/s2468-1253(19)30082-2 Eliminating hepatitis C in Europe
https://doi.org/10.1136/gutjnl-2016-312422 Brexit from current guideline recommendations?
https://doi.org/10.1016/j.jhep.2018.11.017 The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its mother
https://doi.org/10.1016/j.aohep.2023.101178 Reply to: “From NAFLD to MASLD: Promise and pitfalls of a new definition’
https://doi.org/10.1101/562637 The Hsp70/Hsp90 Co-Chaperone Hop/Stip1 Shifts the Proteostatic Balance from Folding Towards Degradation
https://doi.org/10.1055/s-0037-1612696 Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver fibrosis
https://doi.org/10.1055/s-0037-1612693 Liver Fibrosis and Metabolic Alterations in Adults with Homozygous Alpha1-antitrypsin Deficiency (PiZZ Genotype)
https://doi.org/10.1055/s-0040-1716158 Die Augmentation mit Alpha1-Antitrypsin assoziiert bei Patienten mit klassischem Alpha1-Antitrypsin-Mangel (Pi*ZZ-Genotyp) mit besseren Leber-Parametern
https://doi.org/10.1055/s-0040-1716042 Europäische Multicenter-Studie: Leberphänotyp bei Erwachsenen mit compound-heterozygotem Alpha1-Antitrypsin-Mangel (Genotyp Pi*SZ)
https://doi.org/10.1097/txd.0000000000001787 Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults
https://doi.org/10.5281/zenodo.18598222 JHepatology/Interactive_FlowChart: Accessing the BCLC treatment flowchart
https://doi.org/10.5281/zenodo.18595371 Interactive-flowchart: Published Version for The Journal of Hepataology
https://doi.org/10.5281/zenodo.18598221 JHepatology/Interactive_FlowChart: Accessing the BCLC treatment flowchart
https://doi.org/10.5281/zenodo.18591393 Accessing the BCLC treatment flowchart
https://doi.org/10.5281/zenodo.18595372 Interactive-flowchart: Published Version for The Journal of Hepataology